Fig. 1 Laser penetration profiles: (a) NILT penetration as a function of skull thickness in four species using a power density of 700 mW/cm2. NILT penetration decreased through the skulls…
Fig. 1 LCN2 expression was significantly increased in the white matter at 24 h after subarachnoid hemorrhage (SAH). (a) Representative bands of Western blotting of the expression of lipocalin-2 (LCN2)….
Fig. 1 Activation of SFKs results in BBB disruption and brain edema formation in the acute stage, but leads to BBB self-repair and brain edema resolution in the recovery stage…
Fig. 1 Schematic diagram of the custom-designed restraint dish. Rose Bengal is intraperitoneally injected in zebrafish after anesthesia. The zebrafish is submerged in the Petri dish with MS-222 solution (75…
Fig. 1 Graphs showing the correlations of the weight of wet cerebrum (WWC), brain water content (BWC), and neurological scoring (NS) Table 1 Correlations among neurological scoring (NS), weight of…
Fig. 1 Water-maze analysis at one month after GMH. Animals were tested using progressive levels, from cued to spatial trials. (*) <0.05 compared with sham; (#) <0.05 compared with vehicle….
Characteristics Presence (n = 162) Absence (n = 417) p Value Age, y 60.6 ± 13.1 61.6 ± 13.9 nsa Sex nsb Female 110 (67.9 %) 284 (68.1 %) Male 52 (32.1) 133 (31.9) Pre-SAH morbidity nsb mRS…
Fig. 1 Selection of significance value for voxel enhancement maps using T1-weighted spin echo brain MRIs in the cold-injury model. Significantly enhanced voxels after Gd administration appear white. (a) Representative…
© Springer International Publishing Switzerland 2016Richard L. Applegate, Gang Chen, Hua Feng and John H. Zhang (eds.)Brain Edema XVIActa Neurochirurgica Supplement12110.1007/978-3-319-18497-5_29 Signaling Pathway in Cerebral Vasospasm After Subarachnoid Hemorrhage: News Update Lingyun Wu1 and Gang Chen1 (1) Department…
Fig. 1 Time course of plasma glyburide level following oral compared with intravenous bolus followed by 72 h infusion at 3 mg/day dose administration Using an IV formulation of glyburide…
